{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:12:28Z","timestamp":1765887148405},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T00:00:00Z","timestamp":1245369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/eye.2009.143","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T09:43:42Z","timestamp":1245404622000},"page":"735-735","source":"Crossref","is-referenced-by-count":8,"title":["Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's disease"],"prefix":"10.1038","volume":"24","author":[{"given":"J H","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,19]]},"reference":[{"key":"BFeye2009143_CR1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","volume":"90","author":"AE Fung","year":"2006","unstructured":"Fung AE, Rosenfeld PJ, Reichel E . The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006; 90: 1344\u20131349.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2009143_CR2","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ophtha.2008.05.007","volume":"115","author":"SS Wickremasinghe","year":"2008","unstructured":"Wickremasinghe SS, Michalova K, Gilhotra J, Guymer RH, Harper CA, Wong TY et al. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology 2008; 115: 1911\u20131915.","journal-title":"Ophthalmology"},{"key":"BFeye2009143_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00417-007-0754-7","volume":"246","author":"SJ Bakri","year":"2008","unstructured":"Bakri SJ, Larson TA, Edwards AO . Intraocular inflammation following intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 2008; 246: 779\u2013781.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2009143_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","volume":"114","author":"SJ Bakri","year":"2007","unstructured":"Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ . Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007; 114: 855\u2013859.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2009143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:07:52Z","timestamp":1684429672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2009143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,19]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BFeye2009143"],"URL":"https:\/\/doi.org\/10.1038\/eye.2009.143","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,19]]}}}